60 Degrees Pharmaceuticals, Inc. (SXTP)
1.08
-0.05
(-4.42%)
USD |
NASDAQ |
Aug 24, 16:00
1.09
+0.01
(+0.93%)
After-Hours: 20:00
60 Degrees Pharmaceuticals Shareholders Equity (Quarterly) : 2.614M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.614M |
| March 31, 2026 | 4.829M |
| December 31, 2025 | 3.463M |
| September 30, 2025 | 4.430M |
| June 30, 2025 | 2.428M |
| March 31, 2025 | 4.110M |
| December 31, 2024 | 4.036M |
| September 30, 2024 | 6.040M |
| June 30, 2024 | 3.035M |
| March 31, 2024 | 7.20M |
| Date | Value |
|---|---|
| December 31, 2023 | 4.870M |
| September 30, 2023 | 6.554M |
| June 30, 2023 | -22.30M |
| March 31, 2023 | -18.96M |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | -17.58M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Harrow, Inc. | 15.20M |
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
| Johnson & Johnson | 84.97B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.283M |
| Total Liabilities (Quarterly) | 1.754M |
| Debt to Equity Ratio | 0.0578 |
| Current Ratio | 2.325 |
| Net Debt Paydown Yield | 0.02% |